Khmelnitskiy, Ukraine Clinical Trials

A listing of Khmelnitskiy, Ukraine clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. This study evaluates how safe and effective ABBV-154 is in participants treated for moderately to severely active RA. Adverse events and change in the disease activity will be assessed. ABBV-154 is …

antirheumatics
rheumatism
stiffness
methotrexate
Clinic of Scientific Research Institute of Invalid Rehabilitation /ID# 228955
 (64.8 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +255 other locations
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

The purpose of this study is to assess the efficacy and safety of treatment with olaparib (MK-7339) in combination with pembrolizumab (MK-3475) in adults with previously treated, advanced (metastatic and/or unresectable) Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-positive solid tumors.

advanced cancer
solid tumor
measurable disease
cancer
pembrolizumab
Podillya Regional Center of Oncology ( Site 1708)
 (67.7 away) Contact site
  • 16 views
  • 13 Jun, 2021
  • +144 other locations
Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

A phase 2b study to evaluate the long-term efficacy and safety study of ABX464 50mg as maintenance therapy in patients with moderate to severe Ulcerative Colitis.

hematochezia
Ternopil University Hospital
 (62.9 away) Contact site
  • 36 views
  • 04 Feb, 2021
  • +138 other locations
A Study to Evaluate the Efficacy Safety and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of IgPro20 (subcutaneous Ig) treatment in adult subjects with dermatomyositis (DM). The primary objective of this study is to assess the efficacy of IgPro20 subcutaneous (SC) doses in comparison to placebo in adult subjects with DM, as measured by responder …

myopathy
prednisolone
corticosteroids
a 10
rash
Kyiv Railway Clinical Hospital No.2
 (169.7 away) Contact site
  • 13 views
  • 14 Jun, 2021
  • +102 other locations
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

A study designed to evaluate the safety and efficacy of venetoclax plus dexamethasone (VenDex) compared with pomalidomide plus dexamethasone (PomDex) in participants with t(11;14)-positive Relapsed or Refractory Multiple Myeloma.

measurable disease
pomalidomide
proteasome inhibitor
dexamethasone
lenalidomide
Institute of Blood Pathology /ID# 223941
 (134.9 away) Contact site
  • 91 views
  • 14 May, 2021
  • +239 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

myocardial infarction
stemi
arterial disease
percutaneous coronary intervention
diabetes
8040015 - Ternopil University Hospital
 (62.9 away) Contact site
  • 1118 views
  • 13 Jun, 2021
  • +3422 other locations
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

remission
crohn's disease
Ternopil City Public Emergency Medical Care Hospital
 (62.9 away) Contact site
  • 1032 views
  • 22 Feb, 2021
  • +807 other locations
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

remission
abdominal pain
crohn's disease
Ternopil City Public Emergency Medical Care Hospital
 (62.9 away) Contact site
  • 858 views
  • 23 Feb, 2021
  • +780 other locations
Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen

This is a Phase 2, open-label study to evaluate PD-1 inhibitor JTX-4014 alone and in combination with vopratelimab, an ICOS agonist, in biomarker-selected adult subjects with metastatic NSCLC who are PD-1/PD-L1 inhibitor nave and have progressed on a platinum based chemotherapy regimen.

lung carcinoma
pd-1 inhibitor
cancer chemotherapy
measurable disease
Municipal Non-profit Enterprise "SubCarpathian Clinical Oncological Centre of Ivano-Frankivsk RC"
 (108.0 away) Contact site
  • 0 views
  • 09 Jun, 2021
  • +68 other locations
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB Subtype DLBCL (ACE-LY-312)

Phase 3 randomized, double-blind, placebo-controlled, study assessing the efficacy and safety of acalabrutinib plus rituximab,cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) vs placebo plus R-CHOP in subjects 65 years of age with previously untreated non-germinal center diffuse large B-cell lymphoma.

Research Site
 (108.0 away) Contact site
  • 0 views
  • 15 Jun, 2021
  • +214 other locations